Switch theme
Sign up to access all valuation multiples
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
1966
3.5K+
LTM Revenue $249M
LTM EBITDA $50.2M
$226M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Medica Sur has a last 12-month revenue (LTM) of $249M and a last 12-month EBITDA of $50.2M.
In the most recent fiscal year, Medica Sur achieved revenue of $237M and an EBITDA of $46.5M.
Medica Sur expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medica Sur valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $249M | XXX | $237M | XXX | XXX | XXX |
| Gross Profit | $87.7M | XXX | $80.2M | XXX | XXX | XXX |
| Gross Margin | 35% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $50.2M | XXX | $46.5M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $38.6M | XXX | $34.1M | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Profit | $28.1M | XXX | $24.8M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Medica Sur's stock price is MXN 45 (or $2).
Medica Sur has current market cap of MXN 4.3B (or $231M), and EV of MXN 4.2B (or $226M).
See Medica Sur trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $226M | $231M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Medica Sur has market cap of $231M and EV of $226M.
Medica Sur's trades at 1.0x EV/Revenue multiple, and 4.9x EV/EBITDA.
Equity research analysts estimate Medica Sur's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medica Sur has a P/E ratio of 8.2x.
See valuation multiples for Medica Sur and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $231M | XXX | $231M | XXX | XXX | XXX |
| EV (current) | $226M | XXX | $226M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | 4.9x | XXX | XXX | XXX |
| EV/EBIT | 5.9x | XXX | 6.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 8.2x | XXX | 9.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 6.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedica Sur's last 12 month revenue growth is 7%
Medica Sur's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $13K for the same period.
Medica Sur's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medica Sur's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medica Sur and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | 31% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $13K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medica Sur acquired XXX companies to date.
Last acquisition by Medica Sur was XXXXXXXX, XXXXX XXXXX XXXXXX . Medica Sur acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Medica Sur founded? | Medica Sur was founded in 1966. |
| Where is Medica Sur headquartered? | Medica Sur is headquartered in Mexico. |
| How many employees does Medica Sur have? | As of today, Medica Sur has 3.5K+ employees. |
| Is Medica Sur publicy listed? | Yes, Medica Sur is a public company listed on MEX. |
| What is the stock symbol of Medica Sur? | Medica Sur trades under MEDICAB ticker. |
| When did Medica Sur go public? | Medica Sur went public in 1994. |
| Who are competitors of Medica Sur? | Similar companies to Medica Sur include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Medica Sur? | Medica Sur's current market cap is $231M |
| What is the current revenue of Medica Sur? | Medica Sur's last 12 months revenue is $249M. |
| What is the current revenue growth of Medica Sur? | Medica Sur revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Medica Sur? | Current revenue multiple of Medica Sur is 0.9x. |
| Is Medica Sur profitable? | Yes, Medica Sur is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medica Sur? | Medica Sur's last 12 months EBITDA is $50.2M. |
| What is Medica Sur's EBITDA margin? | Medica Sur's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Medica Sur? | Current EBITDA multiple of Medica Sur is 4.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
